These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The effects of tissue-non-specific alkaline phosphatase gene therapy on craniosynostosis and craniofacial morphology in the FGFR2C342Y/+ mouse model of Crouzon craniosynostosis. Wang E, Nam HK, Liu J, Hatch NE. Orthod Craniofac Res; 2015 Apr 01; 18 Suppl 1(0 1):196-206. PubMed ID: 25865549 [Abstract] [Full Text] [Related]
11. Tissue-specific responses to aberrant FGF signaling in complex head phenotypes. Martínez-Abadías N, Motch SM, Pankratz TL, Wang Y, Aldridge K, Jabs EW, Richtsmeier JT. Dev Dyn; 2013 Jan 01; 242(1):80-94. PubMed ID: 23172727 [Abstract] [Full Text] [Related]
13. Crouzon syndrome mouse model exhibits cartilage hyperproliferation and defective segmentation in the developing trachea. Hines EA, Jones MN, Harvey JF, Perlyn C, Ornitz DM, Sun X, Verheyden JM. Sci China Life Sci; 2019 Oct 01; 62(10):1375-1380. PubMed ID: 31463736 [Abstract] [Full Text] [Related]
14. The Fgfr2 W290R mouse model of Crouzon syndrome. Gong SG. Childs Nerv Syst; 2012 Sep 01; 28(9):1495-503. PubMed ID: 22872266 [Abstract] [Full Text] [Related]